Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

计划入组 100 人 · 首次发布于 2024 年 4 月 29 日

Montreal Heart Attack Readjustment Trial (M-HART)

首次发布于 1999 年 10 月 28 日

Heart Institute BioRepository (HIBR) for Pediatric Heart Disease

计划入组 5,000 人 · 首次发布于 2026 年 3 月 17 日

Urokinase plasminogen activator (Baker IDI Heart & Diabetes Institute/University of Melbourne)

Fentanyl analogue(Clinical Research Institute of Montreal)

MBP-0201

Montréal Heart Institute

Canada

TABBA HEART INSTITUTE

Pakistan

ARIZONA HEART INSTITUTE

United States

COSCIENS Biopharma Advances Oat-Derived Anti-Inflammatory Compound to Phase 2a Following Successful Safety Trial

COSCIENS Biopharma Prioritizes Natural Products After Macimorelin Trial Failure

ClearFlow's PleuraFlow System Reduces Cardiac Surgery Complications by 41% in Large Clinical Trial